文献速递白血病淋巴瘤

NOTCH1突变慢性淋巴细胞白血病细胞以MYC相关核磷蛋白1和核糖体相关组分过表达为特征

NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.
PubMed 文献 · Leukemia · 2017-03-21

该研究通过基因表达谱比较NOTCH1突变与野生型慢性淋巴细胞白血病(CLL),发现NOTCH1突变CLL中核糖体生物合成相关基因(如NPM1和核糖体蛋白)上调。体外激活/抑制NOTCH1信号及染色质免疫沉淀实验提示MYC介导NOTCH1对NPM1和核糖体蛋白表达的调控,NPM1可赋予CLL样细胞增殖优势。

要点

  • NOTCH1突变CLL中核糖体生物合成相关基因(NPM1、核糖体蛋白)表达上调。
  • NOTCH1信号激活可上调NPM1表达,抑制NOTCH1信号则降低NPM1表达。
  • MYC介导NOTCH1对NPM1和核糖体蛋白表达的调控,NPM1赋予CLL样细胞增殖优势。

核心结论

  • NOTCH1突变CLL与MYC及MYC相关蛋白生物合成基因(包括NPM1)过表达相关,这些基因据称负责NOTCH1突变CLL的细胞生长和/或增殖优势。

研究设计与样本

  • 研究对NOTCH1突变与NOTCH1野生型CLL进行基因表达谱分析,并开展体外NOTCH1信号激活/抑制、生物信息学分析、染色质免疫沉淀及siRNA转染实验。

主要发现

  • NOTCH1突变CLL基因表达特征为核糖体生物合成相关基因(如NPM1和核糖体蛋白)上调。
  • 乙二胺四乙酸激活NOTCH1信号或与表达JAGGED1的基质细胞共培养可增加NPM1表达。
  • NOTCH1特异性siRNA或γ-分泌酶抑制剂抑制NOTCH1信号可降低NPM1表达。
  • 生物信息学分析及体外NOTCH1信号激活/抑制提示MYC介导NOTCH1对NOTCH1突变CLL中NPM1和核糖体蛋白表达的作用。
  • 在转染NOTCH1胞内结构域(NICD)的CLL样细胞中,染色质免疫沉淀实验显示NOTCH1直接结合MYC启动子,转染MYC特异性siRNA可降低NPM1表达。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In chronic lymphocytic leukemia (CLL), the mechanisms controlling cell growth and proliferation in the presence of NOTCH1 mutations remain largely unexplored. By performing a gene expression profile of NOTCH1-mutated (NOTCH1-mut) versus NOTCH1 wild-type CLL, we identified a gene signature of NOTCH1-mut CLL characterized by the upregulation of genes related to ribosome biogenesis, such as nucleophosmin 1 (NPM1) and ribosomal proteins (RNPs). Activation of NOTCH1 signaling by ethylenediaminetetraacetic acid or by coculture with JAGGED1-expressing stromal cells increased NPM1 expression, and inhibition of NOTCH1 signaling by either NOTCH1-specific small interfering RNA (siRNA) or γ-secretase inhibitor reduced NPM1 expression. Bioinformatic analyses and in vitro activation/inhibition of NOTCH1 signaling suggested a role of MYC as a mediator of NOTCH1 effects over NPM1 and RNP expression in NOTCH1-mut CLL. Chromatin immunoprecipitation experiments performed on NOTCH1 intracellular domain (NICD)-transfected CLL-like cells showed the direct binding of NOTCH1 to the MYC promoter, and transfection with MYC-specific siRNA reduced NPM1 expression. In turn, NPM1 determined a proliferation advantage of CLL-like cells, as demonstrated by NPM1-specific siRNA transfection. In conclusion, NOTCH1 mutations in CLL are associated with the overexpression of MYC and MYC-related genes involved in protein biosynthesis including NPM1, which are allegedly responsible for cell growth and/or proliferation advantages of NOTCH1-mut CLL.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Pozzo F, Bittolo T, Vendramini E, et al. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components. Leukemia. 2017. PMID: 28321119. doi:10.1038/leu.2017.90

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。